No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO Annual Meeting. This abstract does not include a full text component.

Erythropoietin (Eprex (4000 iu)) is a haematopoietic agent, prescribed for anemia in people with chronic kidney failure. It helps in the formation of red blood cells by the bone marrow. The ...

January 19, 2007 — The European Commission has approved levetiracetam for the adjunctive treatment of primary generalized tonic-clonic seizures in patients aged 12 years and older with refractory ...

November 6 (Istanbul) — Cancer patients receiving epoetin to prevent anemia during chemotherapy or radiation treatment fared just as well on once-weekly doses as on the traditional thrice-weekly ...

Iron status is commonly assessed using serum ferritin and transferrin saturation (TSAT) values. As inflammation has an influence on these variables, other more specialized markers have come into use, ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

This meta-analysis of individual patient data was designed to evaluate differences between epoetin beta and control (placebo or standard care) with regard to overall survival and malignancy ...

Fixed-Dose Phosphate Binder Schedules May Be Less than Ideal Researchers confirmed higher dose conversion ratios in Taiwanese patients with stable hemoglobin. For Asian hemodialysis (HD) patients with ...